LHDX News and Press, Lucira Health Inc. From 11/11/21

Lucira Health, Inc. (LHDX) Q3 2021 Earnings Conference Call November 11, 2021 4:30 PM ET Company Participants Greg Chodaczek – Investor Relations Erik Engelson – President and Chief Executive Officer Dan George – Chief Financial Officer Conference Call Participants Derik ...

Gainers: Xponential Fitness (NYSE:XPOF) +18%. Co-Diagnostics (NASDAQ:CODX) +13%. Nkarta (NASDAQ:NKTX) +11%. Oppfi (NYSE:OPFI) +4%. The Vita Coco Company (NYSE:CSPR) +3%. Losers: Acutus Medical (NASDAQ:AFIB) -23%. WM Technology (NASDAQ:MAPS) -13%. Lucira Heal...

Lucira Health (NASDAQ:LHDX): Q3 GAAP EPS of -$0.71 misses by $0.19. Revenue of $14.98M misses by $3.32M. Press Release Lucira Health projects revenue for the fourth quarter of 2021 of at least $30 million ($28.4M consensus) and 2022 revenues in excess of $150 million vs. $85.53M consensus. ...

EMERYVILLE, Calif., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (Nasdaq: LHDX) ("Lucira Health," "Lucira" or the "Company"), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today reported ...

EMERYVILLE, Calif., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health" or "Lucira") (Nasdaq: LHDX), a medical technology company focusing on the development and commercialization of transformative and innovative infectious disease test kits, announced that its LUCIRA...

EMERYVILLE, Calif., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced t...

This FDA Emergency Use Authorization (“EUA”) first PCR quality, single-use, COVID-19 at home, self-test kit can again be purchased via the Company’s website EMERYVILLE, Calif., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health" or "Lucira") (...

EMERYVILLE, Calif., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health" or "Lucira") (Nasdaq: LHDX), a medical technology company focusing on the development and commercialization of transformative and innovative infectious disease test kits, received PSAR approval for it...

EMERYVILLE, Calif., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”) (NASDAQ: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, to...

Cue Health (NASDAQ:HLTH) has priced its IPO of 12.5M shares of common stock at $16.00/share, for gross proceeds of $200M at a target valuation of around $2.4B. Nasdaq trading commences on September 24, 2021. Underwriters' over-allotment is an additional 1.875M shares. Closing date i...